- Home
- CMBM vs CING Comparison
CMBM vs CING Comparison
Compare CMBM & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- CING
- Stock Information
- Founded
- CMBM 2011
- CING 2012
- Country
- CMBM United States
- CING United States
- Employees
- CMBM N/A
- CING N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- CING Health Care
- Exchange
- CMBM Nasdaq
- CING Nasdaq
- Market Cap
- CMBM 25.0M
- CING 22.0M
- IPO Year
- CMBM 2019
- CING 2021
- Fundamental
- Price
- CMBM $0.87
- CING $4.09
- Analyst Decision
- CMBM Buy
- CING Strong Buy
- Analyst Count
- CMBM 1
- CING 4
- Target Price
- CMBM $3.00
- CING $31.00
- AVG Volume (30 Days)
- CMBM 256.9K
- CING 156.0K
- Earning Date
- CMBM 11-06-2025
- CING 11-06-2025
- Dividend Yield
- CMBM N/A
- CING N/A
- EPS Growth
- CMBM N/A
- CING N/A
- EPS
- CMBM N/A
- CING N/A
- Revenue
- CMBM $172,215,000.00
- CING N/A
- Revenue This Year
- CMBM N/A
- CING N/A
- Revenue Next Year
- CMBM $17.73
- CING N/A
- P/E Ratio
- CMBM N/A
- CING N/A
- Revenue Growth
- CMBM N/A
- CING N/A
- 52 Week Low
- CMBM $0.23
- CING $3.02
- 52 Week High
- CMBM $1.69
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- CMBM 52.16
- CING 53.75
- Support Level
- CMBM $0.79
- CING $3.80
- Resistance Level
- CMBM $1.07
- CING $4.24
- Average True Range (ATR)
- CMBM 0.10
- CING 0.22
- MACD
- CMBM -0.01
- CING 0.07
- Stochastic Oscillator
- CMBM 37.19
- CING 81.69
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.